South Korea Antidote Market Size & Outlook, 2023-2030

The antidote market in South Korea is expected to reach a projected revenue of US$ 99.4 million by 2030. A compound annual growth rate of 8.6% is expected of South Korea antidote market from 2024 to 2030.
Revenue, 2023 (US$M)
$55.9
Forecast, 2030 (US$M)
$99.4
CAGR, 2024 - 2030
8.6%
Report Coverage
South Korea

South Korea antidote market highlights

  • The South Korea antidote market generated a revenue of USD 55.9 million in 2023 and is expected to reach USD 99.4 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
  • In terms of segment, chemical antidote was the largest revenue generating type in 2023.
  • Pharmacological antidote is the most lucrative type segment registering the fastest growth during the forecast period.


Antidote market data book summary

Market revenue in 2023USD 55.9 million
Market revenue in 2030USD 99.4 million
Growth rate8.6% (CAGR from 2023 to 2030)
Largest segmentChemical antidote
Fastest growing segmentPharmacological antidote
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationChemical Antidote, Physical Antidote, Pharmacological antidote
Key market players worldwidePfizer Inc, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories, Viatris Inc, Novartis AG ADR, Baxter International Inc, Emergent BioSolutions Inc, Zydus Lifesciences, Fresenius Kabi, Endo Pharmaceuticals


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.6% of the global antidote market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China antidote market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 182.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antidote Market Scope

Antidote market segmentation & scope
Chemical Antidote
Physical Antidote
Pharmacological antidote
Oral
Topical
Injectable
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hospital
Homecare
Specialty Clinics
Others

Antidote Market Companies

Name Profile # Employees HQ Website

South Korea antidote market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antidote market will help companies and investors design strategic landscapes.


Chemical antidote was the largest segment with a revenue share of 42.93% in 2023. Horizon Databook has segmented the South Korea antidote market based on chemical antidote, physical antidote, pharmacological antidote covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Korea antidote market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea antidote market databook

  • Our clientele includes a mix of antidote market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea antidote market , including forecasts for subscribers. This country databook contains high-level insights into South Korea antidote market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea antidote market size, by type, 2018-2030 (US$M)

South Korea Antidote Market Outlook Share, 2023 & 2030 (US$M)

South Korea antidote market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more